COMMUNIQUÉS West-GlobeNewswire

Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
15/03/2019
DUBLIN, Ireland, March 15, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218 for sleep disorders, today announced its financial results for the fourth quarter and [...]
Oncology Venture receives guarantees and undertakings for a proposed rights issue
15/03/2019
Press release Hoersholm, Denmark, March 15, 2019 – Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) today announces that its Board of Directors proposes a rights issue of SEK 60-100 million at the coming [...]
Bbs-Bioactive Bone Substitutes Plc: INVITATION TO ANNUAL GENERAL MEETING
15/03/2019
Stock Exchange Release March 15, 2019 at 12:00 am. INVITATION TO THE BBS-BIOACTIVE BONE SUBSTITUTES PLC’S ANNUAL GENERAL MEETING (AGM) The shareholders of BBS-Bioactive Bone Substitutes Plc are invited to the company’s [...]
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
15/03/2019
Company announcement – No. 5 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, March 15, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), a Copenhagen- [...]
Philips showcases integrated portfolio for efficient and effective cardiac care at ACC.19
15/03/2019
March 15, 2019 Amsterdam, the Netherlands and New Orleans, U.S. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is highlighting its latest innovations in cardiac care at the ACC.19 68th [...]
Notice to convene Herantis Pharma Plc’s Annual General Meeting of shareholders
15/03/2019
Notice to convene Herantis Pharma Plc’s Annual General Meeting of shareholders Herantis Pharma Plc Company release 15 March 2019 at 9:00 am NOTICE TO CONVENE HERANTIS PHARMA PLC’S ANNUAL GENERAL MEETING OF SHAREHOLDERS [...]
Nicox : signature d'un accord sur ZERVIATE pour la Chine. Paiements d'étape et redevances pouvant atteindre 17 millions d'euros
15/03/2019
Communiqué de presse Nicox : signature d'un accord sur ZERVIATE TM pour la Chine. Paiements d'étape et redevances pouvant atteindre 17 millions d'euros ................................................. 15 mars 2019 - [...]
Nicox signs agreement for ZERVIATE in China for up to €17 million in milestone payments plus royalties
15/03/2019
Press Release Nicox signs agreement for ZERVIATE TM in China for up to €17 million in milestone payments plus royalties ................................................ March 15, 2019- release at 7:30 am CET Sophia [...]
Auris Medical Announces 20-F Filing
15/03/2019
Zug, Switzerland, March 15, 2019 (GLOBE NEWSWIRE) -- March 14, 2019 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in [...]
Syneos Health Schedules Fourth Quarter and Year End 2018 Earnings Call for Monday, March 18, 2019
14/03/2019
MORRISVILLE, N.C., March 14, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a Contract Research Organization (CRO) and Contract [...]
Management Cease Trade Order Update
14/03/2019
HALIFAX, Nova Scotia, March 14, 2019 (GLOBE NEWSWIRE) -- MedMira Inc. (TSXV: MIR) (“MedMira” or the “Company”) provides an update with respect to the previously announced management cease trade order (the “MCTO”) issued [...]
Nova Leap Health Corp. Reports Fourth Quarter and Full Year 2018 Financial Results
14/03/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, March 14, 2019 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
Anchiano Therapeutics to Present at the Oppenheimer 29th Annual Healthcare Conference
14/03/2019
CAMBRIDGE, Mass., March 14, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq and TASE: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the discovery and development of novel therapies [...]
Allscripts Partners with Opargo to Drive Improved Patient Care through Optimized Practice Management
14/03/2019
A predictive analytics and optimization engine fully integrated with Allscripts Practice Management to improve scheduling capabilities and practice workflows CHICAGO, March 14, 2019 (GLOBE NEWSWIRE) -- Today, Allscripts [...]
Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2018 Financial Results
14/03/2019
CAMBRIDGE, Mass., March 14, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]
Novelion Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
14/03/2019
Company achieves FY 2018 total net revenues of $130.4 million FY 2018 operating expenses reduced by $27.2 million, or 18.4% VANCOUVER, British Columbia, and CAMBRIDGE, Mass., March 14, 2019 (GLOBE NEWSWIRE) -- Novelion [...]
Athersys Announces Financial Results for Fourth Quarter and Full Year 2018
14/03/2019
Substantial progress over the year, advancing programs and expanding collaboration with HEALIOS K.K. Management to host conference call at 4:30 PM EST today CLEVELAND, March 14, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. ( [...]
Crinetics Pharmaceuticals Announces Upcoming Presentations at ENDO2019
14/03/2019
SAN DIEGO, March 14, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Allakos Reports Fourth Quarter and Full Year 2018 Financial Results and 2018 Corporate Highlights
14/03/2019
REDWOOD CITY, Calif., March 14, 2019 (GLOBE NEWSWIRE) -- Allakos Inc. (Nasdaq: ALLK), a biotechnology company developing AK002 for the treatment of eosinophil and mast cell related diseases, today reported financial [...]

Pages